EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Transepithelial Accelerated Crosslinking for Progressive Keratoconus: A Critical Analysis of Medium-Term Treatment Outcomes

Rodrigo Vilares-Morgado iD, Ana Margarida Ferreira iD, Ana Maria Cunha iD, Raúl Moreira, Luís Torrão iD, Pedro Neves-Cardoso iD, João Pinheiro-Costa iD

Clinical Ophthalmology · 2024-02 · Volume 18 · 393-407

DOI: 10.2147/opth.s450916 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Ophthalmology, 2024-02. Verfasst von Rodrigo Vilares-Morgado und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Centro Hospitalar Universitário de São João, Porto, Portugal. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To report the 4-year outcomes of transepithelial accelerated corneal collagen crosslinking (TE-ACXL) in the treatment of eyes with progressive keratoconus (KC).

Methods

Eyes of patients who underwent TE-ACXL (6mW/cm2 for 15 minutes) for progressive KC and presented 48 months of follow-up were included. Corrected distance visual acuity (CDVA), keratometry measurements (Kmax, maximum keratometry, Kmean, mean keratometry and Astg, corneal astigmatism), thinnest corneal thickness (PachyMin), and topographic, and tomographic indices (specifically the posterior radius of curvature from the 3.0 mm centered on the thinnest point of the cornea (PRC), and the D-index) were analysed preoperatively and every 12 months after TE-ACXL, up to 48 months. Progression after TE-ACXL was considered when eyes presented ≥1 criteria: (1) increase of ≥1D in Kmax or increase of ≥0.75D in Kmean or increase of ≥1D in Astg; (2) reduction of ≥0.085 mm in PRC; (3) decrease ≥5% in PachyMin.

Results

41 eyes from 30 patients were included, with a mean age at crosslinking of 20.90±4.69 years. There was a significant increase in Kmean (+0.64±1.04 D, p

Schlagwörter

Stichwörter der Autor:innen

epi-on crosslinkingkeratoconus progressionprogressive keratoconustrans-epithelial corneal crosslinking

Autor:innen und Institutionen

  • Department of Ophthalmology, Centro Hospitalar Universitário de São João, Porto, Portugal.
  • Department of Surgery and Physiology, Faculty of Medicine of Porto University, Porto, Portugal.
  • Department of Biomedicine, Faculty of Medicine of Porto University, Porto, Portugal.

ORCID-Profile: Rodrigo Vilares-Morgado, Ana Margarida Ferreira, Ana Maria Cunha, Luís Torrão, Pedro Neves-Cardoso, João Pinheiro-Costa

Zitieren

APA

Vilares-Morgado, R., Ferreira, A. M., Cunha, A. M., Moreira, R., Torrão, L., Neves-Cardoso, P., & Pinheiro-Costa, J. (2024). Transepithelial Accelerated Crosslinking for Progressive Keratoconus: A Critical Analysis of Medium-Term Treatment Outcomes. Clinical Ophthalmology, Volume 18, 393-407. https://doi.org/10.2147/opth.s450916

Vancouver

Vilares-Morgado R, Ferreira AM, Cunha AM, Moreira R, Torrão L, Neves-Cardoso P, et al. Transepithelial Accelerated Crosslinking for Progressive Keratoconus: A Critical Analysis of Medium-Term Treatment Outcomes. Clinical Ophthalmology. 2024;Volume 18:393-407. doi:10.2147/opth.s450916

BibTeX
@article{VilaresMorgado2024,
  author = {Vilares-Morgado, Rodrigo and Ferreira, Ana Margarida and Cunha, Ana Maria and Moreira, Raúl and Torrão, Luís and Neves-Cardoso, Pedro and Pinheiro-Costa, João},
  title = {Transepithelial Accelerated Crosslinking for Progressive Keratoconus: A Critical Analysis of Medium-Term Treatment Outcomes},
  journal = {Clinical Ophthalmology},
  year = {2024},
  volume = {Volume 18},
  pages = {393--407},
  doi = {10.2147/opth.s450916}
}
Kostenlos starten →